Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593149 · ClinicalTrials.gov registry record · NA
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
A NA study, sponsored by Pursuit Vascular.
- Completed
- Registry status
- NA
- Development phase
- 1,902
- Enrollment target
NCT02593149 is a NA study that has completed, run by Pursuit Vascular. The registered enrollment target is 1,902 participants.
The verdict
NCT02593149, a NA study, has completed, sponsored by Pursuit Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,902 participants
- Enrollment target
Study Summary
To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port protector.
Interventions
- DEVICE ClearGuard HD End Cap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,902 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593149
The ClinicalTrials.gov registry entry for NCT02593149 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,902 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pursuit Vascular, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ClearGuard HD End Cap is the first listed.
NCT02593149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02593149 about?
NCT02593149 is a clinical study titled "Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap". To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port protector.
What is the current status of trial NCT02593149?
This trial is currently completed. It is a NA study. The enrollment target is 1,902 participants. The study started on 2015-11. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02593149?
The interventions under investigation include: ClearGuard HD End Cap (DEVICE).
Who is sponsoring clinical trial NCT02593149?
This trial is sponsored by Pursuit Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.